BDI Pharma Company Profile
BDI Pharma has continuously refined the concept of niche distribution, providing solutions beyond the traditional wholesaler model since 1995. We operate as an extension of our partners' sales force, create demand, and move market share with each transaction. In this regard, we maintain a highly selective process when entering into a strategic partnership. Our approach of serving the manufactures as well as the customers over nearly two decades has proven successful in varied market conditions. This is further supplemented through innovative supply solutions, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, BDI Pharma’s home web page www.bdipharma.com (also www.ivig.com) has become an industry-renowned point of reference. Proprietary programs covering comprehensive reimbursement services - www.bdiaccess.com and 855-BDI-CARE; and product consignment - www.bdivantageplus.com; round out a family of solutions tailored to the needs of the healthcare community at large.
News from Brad Davis:
Specialty Pharmaceutical Distributor BDI Pharma Ramps Up Growth Initiative With Recent Expansion in Both Current and New Facilities
Company increases cold and frozen storage capabilities, acquires additional facility to accommodate new growth and recent contract gains.
COLUMBIA, S.C., March 24, 2014 /PRNewswire/ – BDI Pharma, Inc. recently completed construction of a new, state-of-the-art refrigeration unit, trip…
Biotech Distributor BDI Pharma Launches The MERREM Commitment Program™ with AstraZeneca for Secure Access to Anti-Bacterial Product MERREM® I.V.
COLUMBIA, S.C., Feb. 20, 2014 /PRNewswire/ – BDI Pharma today announced the launch of The MERREM Commitment Program™ with AstraZeneca, an assurance initiative offering customers security in product availability through contracted access to the original, branded MERREM®I.V. from Ast…
Specialty Pharmaceutical Distributor BDI Pharma Posts Record Sales Revenues for Third Quarter 2013
The company continues to evolve its business platform, experiencing exponential growth year after year
COLUMBIA, S.C., Oct. 31, 2013 /PRNewswire/ – BDI Pharma, Inc. today announced record sales revenues for Q3 2013, representing a 39% increase compared to the same time period in 2012. Thi…
Evolution of Pharmaceutical Distribution Supply Chain is Goal of BDI Pharma, Inc.
BDI’s Linear B Exchange model addresses the rising distribution costs associated with healthcare reform
COLUMBIA, S.C., Aug. 14, 2013 /PRNewswire/ – BDI Pharma, the nation’s fastest growing national distributor of specialty pharmaceuticals, has set its sights on evolving t…